Emerging therapeutic alternatives for snakebite envenoming
| dc.creator | Gutiérrez, José María | |
| dc.date.accessioned | 2026-06-01T19:56:33Z | |
| dc.date.issued | 2019-10-05 | |
| dc.description.abstract | The primary treatment for snakebite envenoming remains the administration of animal-derived antivenoms. While highly effective against systemic manifestations, antivenoms present drawbacks, including the need for trained healthcare staff, limited specificity (being restricted to the venoms used in immunization), and the risk of adverse reactions. | |
| dc.description.procedence | UCR::Vicerrectoría de Investigación::Unidades de Investigación::Ciencias de la Salud::Instituto Clodomiro Picado (ICP) | |
| dc.description.procedence | UCR::Vicerrectoría de Docencia::Salud::Facultad de Microbiología | |
| dc.identifier.doi | https://doi.org/10.1016/j.toxicon.2019.06.044 | |
| dc.identifier.issn | 0041-0101 | |
| dc.identifier.uri | https://hdl.handle.net/10669/104658 | |
| dc.language.iso | eng | |
| dc.rights | acceso embargado | |
| dc.source | Toxicon, 168, supplment 1, 2019 | |
| dc.subject | Snakebite envenoming | |
| dc.subject | Antivenoms | |
| dc.subject | Recombinant antibodies | |
| dc.subject | Toxin inhibitors | |
| dc.subject | Phospholipases A2 | |
| dc.subject | Metalloproteinases | |
| dc.subject | Nanoparticles | |
| dc.title | Emerging therapeutic alternatives for snakebite envenoming | |
| dc.type | contribución de congreso |